Terns to Present at the 19th Annual Virtual Needham HealthCare Conference

Rhea-AI Summary

On April 7, 2021, Terns Pharmaceuticals, a clinical-stage biopharmaceutical firm, announced its participation in the 19th Annual Virtual Needham Healthcare Conference. The presentation is set for April 14 at 11:40 a.m. ET. Interested parties can access a live audio webcast through the conference and Terns’ website, with a replay available for 30 days post-event. Terns focuses on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and chronic liver diseases, utilizing clinically validated mechanisms to benefit patients.

FOSTER CITY, Calif., April 07, 2021 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and other chronic liver diseases, today announced that management will be presenting at the 19^th Annual Virtual Needham Healthcare Conference on Wednesday, April 14 at 11:40 a.m. ET.

A live audio webcast of the presentation will be available on the conference website and on Terns’ website. A replay of the webcast will be archived on Terns’ website for 30 days following the presentation.

About Terns Pharmaceuticals
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns’ programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients. For more information, please visit www.ternspharma.com.

Contacts for Terns

Investors
Mark Vignola
investors@ternspharma.com

Media
Cory Tromblee
media@ternspharma.com

FAQ

What event will Terns Pharmaceuticals present at on April 14, 2021?

Terns Pharmaceuticals will present at the 19th Annual Virtual Needham Healthcare Conference.

What time is Terns Pharmaceuticals' presentation at the Needham Healthcare Conference?

The presentation is scheduled for 11:40 a.m. ET on April 14, 2021.

How can I access Terns Pharmaceuticals' presentation during the conference?

You can access a live audio webcast of the presentation on the conference website and Terns' website.

Will there be a replay of Terns Pharmaceuticals' conference presentation?

Yes, a replay of the webcast will be available on Terns' website for 30 days following the presentation.

What is Terns Pharmaceuticals' focus in drug development?

Terns Pharmaceuticals develops therapies for non-alcoholic steatohepatitis (NASH) and chronic liver diseases.